免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Achilles Non-SNIS REGENETEN

NCT:NCT07869121 · ENROLLING_BY_INVITATION

NCT编号NCT07869121
状态ENROLLING_BY_INVITATION
开始日期2026-08-03
完成时间2028-12-31
SponsorOrthoCarolina Research Institute, Inc. (OTHER)
First posted
Last updated

简要摘要

The proposed study addresses this gap by prospectively evaluating patient-reported outcomes, imaging endpoints, and safety through 12 months after BCI-augmented repair in IAT and MSR patients. The purpose is to evaluate clinical outcomes (effectiveness) following the use of REGENETEN to augment Achilles tendon surgical procedures.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑